rs116000902
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2
The NM_001018116.2(CAVIN4):c.408+6C>A variant causes a splice donor region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00108 in 1,612,612 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0058 ( 8 hom., cov: 32)
Exomes 𝑓: 0.00059 ( 7 hom. )
Consequence
CAVIN4
NM_001018116.2 splice_donor_region, intron
NM_001018116.2 splice_donor_region, intron
Scores
2
Splicing: ADA: 0.0001256
2
Clinical Significance
Conservation
PhyloP100: -0.270
Genes affected
CAVIN4 (HGNC:33742): (caveolae associated protein 4) This gene encodes a protein containing two coiled-coil regions. The encoded protein promotes Rho/ROCK (Rho-kinase) signaling in cardiac muscles cells, and may facilitate myofibrillar organization. [provided by RefSeq, Jun 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
?
Computational evidence support a benign effect (BayesDel_noAF=-0.34).
BP6
?
Variant 9-100578557-C-A is Benign according to our data. Variant chr9-100578557-C-A is described in ClinVar as [Benign]. Clinvar id is 390964.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
?
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00579 (881/152276) while in subpopulation AFR AF= 0.02 (833/41548). AF 95% confidence interval is 0.0189. There are 8 homozygotes in gnomad4. There are 403 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
?
High Homozygotes in GnomAd at 8 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CAVIN4 | NM_001018116.2 | c.408+6C>A | splice_donor_region_variant, intron_variant | ENST00000307584.6 | |||
CAVIN4 | XM_047423346.1 | c.384+6C>A | splice_donor_region_variant, intron_variant | ||||
CAVIN4 | XM_047423347.1 | c.21+1602C>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CAVIN4 | ENST00000307584.6 | c.408+6C>A | splice_donor_region_variant, intron_variant | 1 | NM_001018116.2 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.00580 AC: 882AN: 152158Hom.: 8 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
882
AN:
152158
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00160 AC: 389AN: 242746Hom.: 1 AF XY: 0.00120 AC XY: 159AN XY: 132572
GnomAD3 exomes
AF:
AC:
389
AN:
242746
Hom.:
AF XY:
AC XY:
159
AN XY:
132572
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000589 AC: 860AN: 1460336Hom.: 7 Cov.: 33 AF XY: 0.000496 AC XY: 360AN XY: 726434
GnomAD4 exome
AF:
AC:
860
AN:
1460336
Hom.:
Cov.:
33
AF XY:
AC XY:
360
AN XY:
726434
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.00579 AC: 881AN: 152276Hom.: 8 Cov.: 32 AF XY: 0.00541 AC XY: 403AN XY: 74442
GnomAD4 genome
?
AF:
AC:
881
AN:
152276
Hom.:
Cov.:
32
AF XY:
AC XY:
403
AN XY:
74442
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 24, 2014 | 408+6C>A in intron 1 of MURC: This variant is not expected to have clinical sign ificance because it has been identified in 1.8% (77/4394) of African American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS; dbSNP rs116000902). - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 12, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at